Drug ID: | NPD2916 |
Drug Name: | RS-2135 |
Molecular Formula: | C18H20N2O2 |
Canonical SMILES: | N[C@@H]1Cc2c3c(O)cccc3n3c2[C@@H]2[C@H]1CCC[C@@H]2CC3=O |
Standard InCHI: | InChI=1S/C18H20N2O2/c19-12-8-11-17-13(5-2-6-14(17)21)20-15(22)7-9-3-1-4-10(12)16(9)18(11)20/h2,5-6,9-10,12,16,21H,1,3-4,7-8,19H2/t9-,10+,12-,16+/m1/s1 |
Standard InCHIKey: | OECDXEBJRAHXDW-HDINQQKLSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB013593 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 296.15 |
ALogP | -2.2215 |
MLogP | 3 |
XLogP | 2.078 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 2 |
TPSA | 68.25 |
RO5 Violation | 0 |